Keywords: US, Drug pricing, GAO, House of Representatives

US Committee leaders call for GAO analysis of recent prescription drug price increases

Article | 19 November 2009

Following recent allegations in the New York Times, and rebuttals by the US research-based pharmaceutical industry (The Pharma Letter November 18), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in